Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Chiltern welcomes Gastroenterology, Oncology and Pediatric Therapeutic experts to their team

February 9, 2012 Research and Development

 Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Drs. Marcelo Piccirillo and Carlo Lanza have joined …
News
Press release

Regulis win the TOPRA* Award for Support

February 9, 2012 Research and Development

News
Press release

European Medicines Agency and European Food Safety Authority commit to a stronger collaboration

February 9, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The European Medicines Agency (EMA) and the European Food Safety Authority (EFSA) have agreed to work closer together on areas …
News
Press release
GSK picture

GSK posts strong underlying sales growth

February 8, 2012 Research and Development, Sales and Marketing Avodart, GSK, R&D, Seretide, Witty, rotarix

GlaxoSmithKline has posted strong underlying growth for 2011, but warns of a tough year ahead.  The UK firm saw 4% …
News

Hospira appoints Richard Davies as chief commercial officer

February 8, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hospira, Richard Davies

Hospira has announced Richard Davies as its senior vice president and chief commercial officer. In this role, he will be responsible for …
Appointment
Breast cancer image

Breast cancer treatment – the next advances

February 7, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Afinitor, CDF, Lorena Tonarelli, T-DM1, breast cancer, pertuzumab

When a close member of my family was diagnosed with breast cancer, the doctors didn’t give us much hope. They …
Feature

Dr Stephen Rosevear joins Cogent as director of Research & Policy

February 7, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cogent, Stephen Rosevear

Prior to joining Cogent, Stephen was HMRC’s chief analyst on the corporate real estate market, undertaking tax modeling and policy development for …
Appointment

Working Life: Carlos Gallardo, general manager, Almirall

February 2, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall, Carlos Gallardo

BiographyCarlos Gallardo is general manager of the Almirall UK and Ireland affiliate from its creation in 2008. He has an …
Feature
AstraZeneca picture

AstraZeneca to cut 7,300 jobs as growth stalls

February 2, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing AZ, AstraZeneca, David Brennan, R&D

AstraZeneca will make 7,300 cuts to its sales and R&D staff by 2014, but the company has not yet said …
News

Sigma-Aldrich acquires testing company BioReliance

February 1, 2012 Research and Development Sigma-Aldrich

Sigma-Aldrich has acquired clinical testing company BioReliance for $350 million. Purchased from Avista Capital Partners, BioReliance provides services that include …
News

Dietmar Leitner joins Napp Pharmaceuticals as its new managing director

January 31, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Dietmar Leitner, Napp Pharmaceuticals

Dietmar Leitner has been appointed managing director of Napp Pharmaceuticals, part of the Napp Pharmaceutical Group.   Dietmar has worked …
Appointment

Pfizer in talks on Sandwich site sale

January 30, 2012 Research and Development Pfizer, Sandwich

Pfizer has begun talks with a real estate investor to sell its R&D centre in Sandwich. The site was Pfizer’s …
News

James Murdoch steps down from GSK board

January 27, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, James Murdoch

GlaxoSmithKline has announced that after nine years with the firm, Sir Crispin Davis, Sir Robert Wilson and Larry Culp will …
Appointment
Boehringer picture

Boehringer broadens afatinib studies

January 27, 2012 Research and Development, Sales and Marketing Boehringer Ingelheim, Cancer, afatinib

Boehringer Ingelheim is expanding the scope of its studies into afatinib to test its use against head and neck cancers. …
News
Amgen picture

Amgen buys Micromet for $1.2 billion

January 27, 2012 Research and Development, Sales and Marketing Amgen. Micromet, blinatumomab

Amgen is to buy German biotech firm Micromet for $1.16 billion to broaden its mid-stage pipeline and consolidate its oncology …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025